PTEN and neoplasm: Proof-of concept in vivo studies using miR-17/106a overexpressing tumor cells clearly showed accelerated tumor development in immunocompromised mice that was efficiently counteracted upon pterostilbene treatment, which resulted in enhanced PTEN expression and apoptosis.